Holding(s) in Company

RNS Number : 0646B
Deltex Medical Group PLC
10 April 2012
 



 


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Deltex Medical Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

X

An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

SFM UK Management LLP

4. Full name of shareholder(s)
 (if different from 3.):iv

Quantum Partners LP

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

April 4, 2012

6. Date on which issuer notified:

April 5, 2012

7. Threshold(s) that is/are crossed or
reached:
vi, vii

3% of the revised shares in issue of 149,767,194



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

N/A

N/A

N/A

N/A

N/A


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Contract for Difference

N/A

N/A

N/A

4,900,000

 

Nominal

Delta

3.27%

3.72%


Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,900,000

3.72%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

This statement relates to a Contract for Difference ("CFD") held for the account of Quantum Partners LP, a

Cayman Islands exempted limited partnership ("Quantum Partners"). SFM UK Management LLP, a sub-advisor to Soros Fund Management LLC, serves as investment manager to Quantum Partners and has

been granted investment discretion over portfolio investments, including the CFD, held for the account of

Quantum Partners.

 


Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A



13. Additional information:


N/A

14. Contact name:

Jade Cornell

Compliance Officer

SFM UK Management LLP

15. Contact telephone number:

020 7758 4826

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASLEFSSAEFF
UK 100

Latest directors dealings